Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$14.74
$14.62
$6.38
$14.76
$1.87B0.193.08 million shs3.45 million shs
Canacol Energy Ltd stock logo
CNE
Canacol Energy
C$1.60
-8.0%
C$2.36
C$1.60
C$4.45
C$38.89M0.8229,208 shs89,705 shs
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
$1.19
-7.0%
$1.73
$1.18
$3.23
$43.65M0.976,937 shs10,199 shs
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
$86.93
$86.93
$78.50
$103.13
$3.65MN/A450 shsN/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00%0.00%0.00%0.00%0.00%
Canacol Energy Ltd stock logo
CNE
Canacol Energy
-8.05%-20.40%-26.27%-43.66%-63.13%
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
-7.03%-19.59%-24.68%-41.67%-62.46%
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/AN/AN/AN/A
Canacol Energy Ltd stock logo
CNE
Canacol Energy
N/AN/AN/AN/AN/AN/AN/AN/A
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
1.525 of 5 stars
0.05.00.80.01.80.01.3
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BELLUS Health Inc. stock logo
BLU
BELLUS Health
0.00
N/AN/AN/A
Canacol Energy Ltd stock logo
CNE
Canacol Energy
0.00
N/AN/AN/A
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
0.00
N/AN/AN/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BELLUS Health Inc. stock logo
BLU
BELLUS Health
$15K124,613.93N/AN/A$3.09 per share4.77
Canacol Energy Ltd stock logo
CNE
Canacol Energy
C$253.21M0.15C$0.43 per share3.68C$10.16 per share0.16
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
N/AN/AN/AN/AN/AN/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BELLUS Health Inc. stock logo
BLU
BELLUS Health
-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/A
Canacol Energy Ltd stock logo
CNE
Canacol Energy
C$16.10MC$0.931.72N/A6.36%6.51%8.32%N/A
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
N/A$0.891.34N/AN/AN/AN/AN/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/A0.00N/AN/AN/AN/AN/A

Latest BLU, CNE, CNNEF, and WIL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
$0.90$0.41-$0.49$0.41$77.00 million$64.81 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/AN/AN/AN/AN/A
Canacol Energy Ltd stock logo
CNE
Canacol Energy
C$1.0465.00%N/A111.83%N/A
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
$0.1915.97%N/A21.35%N/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/A0.00%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BELLUS Health Inc. stock logo
BLU
BELLUS Health
N/A
33.42
33.42
Canacol Energy Ltd stock logo
CNE
Canacol Energy
209.68
1.50
1.34
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
N/AN/AN/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
90.37%
Canacol Energy Ltd stock logo
CNE
Canacol Energy
23.47%
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
N/A
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/A

Insider Ownership

CompanyInsider Ownership
BELLUS Health Inc. stock logo
BLU
BELLUS Health
24.17%
Canacol Energy Ltd stock logo
CNE
Canacol Energy
20.60%
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
2.50%
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BELLUS Health Inc. stock logo
BLU
BELLUS Health
74126.81 million96.16 millionNot Optionable
Canacol Energy Ltd stock logo
CNE
Canacol Energy
39624.31 millionN/ANot Optionable
Canacol Energy Ltd stock logo
CNNEF
Canacol Energy
39634.10 millionN/ANot Optionable
Barclays Women in Leadership ETN stock logo
WIL
Barclays Women in Leadership ETN
2,02042,000N/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BELLUS Health stock logo

BELLUS Health NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Canacol Energy stock logo

Canacol Energy TSE:CNE

C$1.60 -0.14 (-8.05%)
As of 08/14/2025 03:59 PM Eastern

Canacol Energy Ltd is a natural gas and oil exploration and production company. The company operates in the Lower & Middle Magdalena Basins of Colombia.

Canacol Energy stock logo

Canacol Energy OTCMKTS:CNNEF

$1.19 -0.09 (-7.03%)
As of 08/14/2025 03:41 PM Eastern

Canacol Energy Ltd operates as an oil and gas company in Colombia. It engages in the exploration and development of natural gas. The company was formerly known as BrazAlta Resources Corp. and changed its name to Canacol Energy Ltd in February 2009. The company was incorporated in 1970 and is headquartered in Calgary, Canada. Canacol Energy Ltd operates as a subsidiary of CDS Clearing and Depository Services Inc.

Barclays Women in Leadership ETN stock logo

Barclays Women in Leadership ETN NYSEARCA:WIL

$86.93 0.00 (0.00%)
As of 12/23/2022